secwatch.observer — SEC 8-K summary
======================================

Issuer:     CORVEL CORP (CRVL)
CIK:        0000874866
Form:       8-K
Filed at:   2026-05-19T23:30:14+00:00
Accession:  0001193125-26-231354
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CorVel Q4 FY2026 EPS $0.61 (+20% YoY); FY revenue $959M (+7%)
-------------------------------------------------------------

- FY revenue $959M (+7% from $896M); FY diluted EPS $2.14 (+17% from $1.83).
- Q4 revenue $249M (+7% YoY); Q4 EPS $0.61 (+20% YoY).
- Q4 gross profit $63M (25% margin, +9% YoY); ended quarter with $233M cash, no debt.
- Repurchased $20.1M of common stock during the quarter.
- CERIS health division seeing large payer implementations; P&C services advancing AI tools.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874866/000119312526231354/0001193125-26-231354-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874866/000119312526231354/crvl-20260520.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-231354

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer